Applying recent advances in the science of CFTR-based therapeutics to improve outcomes in patients with cystic fibrosis

Academic Article

Abstract

  • © 2017 European Cystic Fibrosis Society. The content for this activity is based on the satellite symposium, "Applying Recent Advances in the Science of CFTR-based Therapeutics to Improve Outcomes in Patients With Cystic Fibrosis", that was presented at the 30th Annual North American Cystic Fibrosis Conference in Orlando, Florida on October 28, 2016 (Online access: http://courses.elseviercme.com/nacfc16/655e). The content highlights the latest advancements, particularly in CFTR-based therapeutics, for the treatment of patients with cystic fibrosis. Expert faculty discuss the most up-to-date analysis for clinical decision-making, including updates on assessment, monitoring, and management of patients treated with CFTR modulator therapies. The goal of this activity is to increase the knowledge and competencies of the multidisciplinary team involved in the management of patients with CF, and provide strategies for improving the lives of patients. Upon completion of this activity, healthcare providers will be better equipped with imperative information for creating more effective personalized treatment plans and improving patient outcomes.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Authorlist

  • Clancy JP; Benitez DS; Fajac I; Jain M; Rowe SM; Sawicki G